This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ariad Pharma CEO 'Retires' in Settlement With Activist Hedge Fund

04/29/15 - 09:01 AM EDT

Sarissa Capital, which owns almost 7% of Ariad, started a proxy fight last February to wrest control of the board and force Berger's ouster.

READ FULL POST

Gilead Should Buy Vertex Pharma for $45B Now, Analyst Says

04/21/15 - 07:48 AM EDT

Gilead Sciences should solve its long-term revenue cliff problem by acquiring Vertex Pharmaceuticals and its growing cystic fibrosis drug franchise for $45 billion, says Bernstein analyst Geoff Porges.

READ FULL POST

Juno, Kite CAR-T Stocks Fall on Disappointing Solid Tumor Data

04/20/15 - 10:22 AM EDT

Shares of Juno Therapeutics and Kite Pharma are weak Monday following a lackluster showing for so-called CAR-T cellular therapies in solid tumors at a closely watched cancer conference this weekend.

READ FULL POST

If SpaceX CEO Musk was Biotech CEO, Rocket's 'Landing' Big Win

04/16/15 - 09:07 AM EDT

In which Musk learns how to put a happy spin on failure from biotech CEOs.

READ FULL POST

Cancer Immunotherapy Remains Hot as Aduro Biotech Doubles in Value On IPO Debut

04/15/15 - 11:35 AM EDT

Aduro Biotech shares doubled in value Wednesday following a successful initial public offering -- another sign that investor demand for cancer immunotherapy stocks remains strong.

READ FULL POST

Stock Index Tracking Red-Hot Cancer Immunotherapy Field Launched

04/07/15 - 08:02 AM EDT

The Loncar Cancer Immunotherapy Index (LCINDX) tracks biopharma companies developing (or already marketing) drugs which use the body's own immune system to target and kill cancer cells.

READ FULL POST

The Top-Performing Biotech Stock During a Sizzling First Quarter

04/01/15 - 09:30 AM EDT

That was one crazy first quarter for the biotech sector. Here's where biotech stocks stand on April Fool's Day.

READ FULL POST

Bankrupt Introgen Seeks Reincarnation IPO in Biotech Bubble

03/31/15 - 11:30 AM EDT

Will the biotech bubble support the comeback of Introgen Therapeutics, one of the sector's largest disasters?

READ FULL POST

Biotech Merger Monday Doesn't Squash Biotech Bubble Debate

03/30/15 - 10:43 AM EDT

Neither of the deals announced Monday are blockbusters or particularly transformative. Both buyers have specific needs and went after small targets for large prices.

READ FULL POST

PTC Therapeutics CEO Liquidates Stock Ownership in His Own Company

03/24/15 - 10:39 AM EDT

Biotech CEOs are supposed to be cheerleaders for their stock, so it's noteworthy when a CEO's pocketbook indicates otherwise.

READ FULL POST

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs